Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo

Lai Fa Sheu, Ann Chen, Ching Liang Meng, Kuo Chieh Ho, Wei Hwa Lee, Fur Jiang Leu, Chung Faye Chao

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) and mostly classified as poorly differentiated squamous cell carcinoma or undifferentiated carcinoma with early metastasis and a rapidly progressive clinical course. The EBV-encoded latent proteins, Epstein-Barr nuclear antigen 1 (EBNA 1) and latent membrane proteins (LMPs), may be expressed in NPC, but their biological effects are poorly understood. EBNA 1 may predispose B lymphocytes to lymphomagenesis in transgenic mice, but its biological effects in NPC are still unknown. This study investigated the biological effects of EBNA I by expressing it in an EBV-negative NPC cell line (HONE-1), which was then inoculated into both nude and severe combined immunodeficiency mice. The EBNA 1 caused HONE-1 cells to grow in a less differentiated pattern and to progress more rapidly, as well as increasing their tumourigenicity and metastatic capability. These data suggest that EBNA 1 may play a critical role in the progressive evolution of NPC.

Original languageEnglish
Pages (from-to)243-248
Number of pages6
JournalJournal of Pathology
Volume180
Issue number3
DOIs
Publication statusPublished - Nov 1996
Externally publishedYes

Fingerprint

Nuclear Antigens
Human Herpesvirus 4
Severe Combined Immunodeficiency
Transgenic Mice
Squamous Cell Carcinoma
Membrane Proteins
B-Lymphocytes
Nasopharyngeal carcinoma
Neoplasm Metastasis
Carcinoma
Cell Line
Proteins

Keywords

  • Epstein-Barr virus
  • Nasopharyngeal carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. / Sheu, Lai Fa; Chen, Ann; Meng, Ching Liang; Ho, Kuo Chieh; Lee, Wei Hwa; Leu, Fur Jiang; Chao, Chung Faye.

In: Journal of Pathology, Vol. 180, No. 3, 11.1996, p. 243-248.

Research output: Contribution to journalArticle

Sheu, Lai Fa ; Chen, Ann ; Meng, Ching Liang ; Ho, Kuo Chieh ; Lee, Wei Hwa ; Leu, Fur Jiang ; Chao, Chung Faye. / Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. In: Journal of Pathology. 1996 ; Vol. 180, No. 3. pp. 243-248.
@article{0740d9889140407896105d2ba110dec6,
title = "Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo",
abstract = "Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) and mostly classified as poorly differentiated squamous cell carcinoma or undifferentiated carcinoma with early metastasis and a rapidly progressive clinical course. The EBV-encoded latent proteins, Epstein-Barr nuclear antigen 1 (EBNA 1) and latent membrane proteins (LMPs), may be expressed in NPC, but their biological effects are poorly understood. EBNA 1 may predispose B lymphocytes to lymphomagenesis in transgenic mice, but its biological effects in NPC are still unknown. This study investigated the biological effects of EBNA I by expressing it in an EBV-negative NPC cell line (HONE-1), which was then inoculated into both nude and severe combined immunodeficiency mice. The EBNA 1 caused HONE-1 cells to grow in a less differentiated pattern and to progress more rapidly, as well as increasing their tumourigenicity and metastatic capability. These data suggest that EBNA 1 may play a critical role in the progressive evolution of NPC.",
keywords = "Epstein-Barr virus, Nasopharyngeal carcinoma",
author = "Sheu, {Lai Fa} and Ann Chen and Meng, {Ching Liang} and Ho, {Kuo Chieh} and Lee, {Wei Hwa} and Leu, {Fur Jiang} and Chao, {Chung Faye}",
year = "1996",
month = "11",
doi = "10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7",
language = "English",
volume = "180",
pages = "243--248",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo

AU - Sheu, Lai Fa

AU - Chen, Ann

AU - Meng, Ching Liang

AU - Ho, Kuo Chieh

AU - Lee, Wei Hwa

AU - Leu, Fur Jiang

AU - Chao, Chung Faye

PY - 1996/11

Y1 - 1996/11

N2 - Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) and mostly classified as poorly differentiated squamous cell carcinoma or undifferentiated carcinoma with early metastasis and a rapidly progressive clinical course. The EBV-encoded latent proteins, Epstein-Barr nuclear antigen 1 (EBNA 1) and latent membrane proteins (LMPs), may be expressed in NPC, but their biological effects are poorly understood. EBNA 1 may predispose B lymphocytes to lymphomagenesis in transgenic mice, but its biological effects in NPC are still unknown. This study investigated the biological effects of EBNA I by expressing it in an EBV-negative NPC cell line (HONE-1), which was then inoculated into both nude and severe combined immunodeficiency mice. The EBNA 1 caused HONE-1 cells to grow in a less differentiated pattern and to progress more rapidly, as well as increasing their tumourigenicity and metastatic capability. These data suggest that EBNA 1 may play a critical role in the progressive evolution of NPC.

AB - Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) and mostly classified as poorly differentiated squamous cell carcinoma or undifferentiated carcinoma with early metastasis and a rapidly progressive clinical course. The EBV-encoded latent proteins, Epstein-Barr nuclear antigen 1 (EBNA 1) and latent membrane proteins (LMPs), may be expressed in NPC, but their biological effects are poorly understood. EBNA 1 may predispose B lymphocytes to lymphomagenesis in transgenic mice, but its biological effects in NPC are still unknown. This study investigated the biological effects of EBNA I by expressing it in an EBV-negative NPC cell line (HONE-1), which was then inoculated into both nude and severe combined immunodeficiency mice. The EBNA 1 caused HONE-1 cells to grow in a less differentiated pattern and to progress more rapidly, as well as increasing their tumourigenicity and metastatic capability. These data suggest that EBNA 1 may play a critical role in the progressive evolution of NPC.

KW - Epstein-Barr virus

KW - Nasopharyngeal carcinoma

UR - http://www.scopus.com/inward/record.url?scp=10544223747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10544223747&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7

DO - 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7

M3 - Article

VL - 180

SP - 243

EP - 248

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -